Prophylactic use of a combination of palonosetron hydrochloride and dexamethasone to prevent transcatheter arterial chemoembolization-induced nausea and vomiting among patients with hepatocellular carcinoma.

Front Med (Lausanne) · 2025 · PMC12832680 · PMID 41601781

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

For instance, although the difference in vomiting incidence between the PH and PH + DXMS groups did not reach statistical significance ( p = 0.06), the downward trend suggests a potential clinical relevance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.